Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L

J. K. Lee, N. Seki, T. J. Sayers, J. Subleski, E. M. Gruys, William J Murphy, R. H. Wiltrout

Research output: Contribution to journalArticle

23 Scopus citations


CD40, a member of the TNF receptor superfamily, is expressed on B cells, dendritic cells, and some tumor cells, including melanoma and bladder carcinoma. In this study, we report that both mouse and human renal carcinoma cells (RCC) also constitutively express functional CD40. Treatment of mouse RCC with CD40L induced strong expression of genes and proteins for ICAM-1 and Fas, and this expression was further enhanced by combining CD40L with IFN-γ. Similar effects were demonstrated using an agonist anti-CD40 antibody. The increased levels of Fas expression on RCC after treatment with CD40L plus IFN-γ resulted in potent killing by either FasL-positive effector cells or agonistic anti-Fas antibody. The combination of CD40L plus IFN-γ also significantly enhanced killing of RCC by tumor-specific CTL lines. Our results demonstrate that constitutively expressed CD40 is functionally active and may provide a molecular target for the development of new approaches to the treatment of RCC.

Original languageEnglish (US)
Pages (from-to)145-152
Number of pages8
JournalCellular Immunology
Issue number2
StatePublished - Jun 2005
Externally publishedYes



  • CD40
  • Cytotoxicity
  • Renal cancer
  • Tumor immunity

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this